SOBR Safe, Inc. - SOBR STOCK NEWS

SOBRsafe (NASDAQ:SOBR) announced it has regained compliance with Nasdaq's listing requirements, including minimum bid price, public float, and stockholders' equity rules. The company will continue trading on The Nasdaq Capital Market under 'SOBR'. Following the October 30, 2024 compliance letter, SOBRsafe enters a mandatory one-year monitoring period. If found non-compliant with the Equity Rule during this period, the company will face immediate delisting procedures without a cure period, though it may request a new hearing.

SOBRsafe, Inc. (NASDAQ:SOBR) has launched a fully-integrated enterprise software solution for alcohol detection and monitoring in behavioral health settings. The platform combines SOBRcheck™ for point-of-care screening and SOBRsure™ for continuous monitoring, offering real-time visibility across multiple users and locations in one dashboard.

Key features include:

• Touch-based transdermal alcohol detection, eliminating need for breath, blood, or urine samples
• Instant reporting accessible via computer or mobile device
• Integration with electronic medical records (EMR)
• Robust lookback capabilities for demonstrating compliance

This innovative solution aims to transform how behavioral health providers monitor alcohol use, enhance responsiveness, reduce recidivism, and improve patient outcomes in addiction and alcohol use disorder (AUD) treatment.

SOBR Safe, Inc. (NASDAQ:SOBR) has successfully completed a private placement of $8.2 million, with Aegis Capital Corp. acting as the exclusive placement agent. This financial transaction, announced on October 9, 2024, represents a significant capital raise for the company. The private placement structure suggests that the shares were offered to a select group of investors rather than the general public.

While the press release does not provide details on the specific use of funds or the terms of the placement, such capital raises are typically used to support company growth, fund research and development, or strengthen the balance sheet. For SOBR Safe, this injection of capital could potentially accelerate its business initiatives and enhance its market position.

SOBRsafe (NASDAQ:SOBR), a provider of transdermal alcohol detection solutions, has closed a private placement with institutional investors, raising $8.2 million in gross proceeds. The company issued 2,024,691 units at $4.05 per unit, each consisting of one share of common stock (or pre-funded warrant) and multiple warrants. The Series A warrants are exercisable at $3.80 per share with a 5-year term, while the Series B warrants have a nominal exercise price. Both warrant series are subject to adjustments. Aegis Capital Corp. acted as the exclusive placement agent. The funds will be used for general corporate purposes and working capital. SOBRsafe has agreed to file registration statements for the resale of the securities.

SOBRsafe (NASDAQ:SOBR), a provider of transdermal alcohol detection solutions, has announced the pricing of a $8.2 million private placement with institutional investors. The company plans to issue 2,024,691 units at $4.05 per unit, each consisting of one common stock share (or pre-funded warrant) and multiple warrants. The Series A warrants are exercisable at $3.80 per share, while the Series B warrants have a $0.001 exercise price.

The private placement is expected to close around October 8, 2024, subject to customary conditions. Aegis Capital Corp. is acting as the Exclusive Placement Agent. SOBRsafe intends to use the net proceeds for general corporate purposes and working capital. The company has agreed to file registration statements with the SEC for the resale of the securities issued in this private placement.

SOBRsafe, a provider of transdermal alcohol detection solutions, has announced international expansion opportunities in India, Italy, and Australia/New Zealand. In India, a critical infrastructure developer has selected SOBRcheck™ for a paid proof-of-concept installation in a public facility. In Italy, a global employer with a fleet of over 10,000 vehicles in Europe has chosen SOBRsure™ wristbands for fleet drivers. In Australia and New Zealand, courts have approved SOBRsafe's technology for use in family law cases, opening up marketing opportunities to over 7,000 family law attorneys in the region.

CEO Dave Gandini highlighted the importance of these developments, noting the high rate of alcohol dependence in India, the EU's "Vision Zero" initiative for road safety, and the potential for expansion into the U.S. family law vertical. The company plans to evaluate the potential for strategic international expansion at the end of Q1 2025 based on the outcomes of these opportunities.

SOBRsafe (NASDAQ:SOBR) has announced a 1-for-110 reverse stock split of its common stock, effective October 2, 2024. The primary goal is to increase the per share market price to regain compliance with Nasdaq's minimum bid price requirement. When effective, every 110 shares will be combined into one share, with no fractional shares issued. The stock will continue trading under the symbol 'SOBR' with a new CUSIP number. Equiniti Trust Company is acting as the exchange agent and transfer agent. Stockholders with book-entry shares don't need to take action, while those with certificated shares will receive instructions from Equiniti. The split applies equally to all outstanding shares and common share equivalent securities.

SOBRsafe (NASDAQ:SOBR), a provider of advanced transdermal alcohol detection solutions, has released a video update from CEO Dave Gandini. The video, available at https://tinyurl.com/3ubmzdcm, offers insights into the company's capital markets, sales, and marketing strategies. This update aims to provide shareholders and potential investors with a comprehensive overview of SOBRsafe's current position and future plans in the alcohol detection technology sector.

SOBRsafe (NASDAQ:SOBR), a provider of advanced transdermal alcohol detection solutions, has launched a national marketing campaign targeting behavioral health providers. The comprehensive B2B initiative aims to introduce SOBRsafe™ technology and drive sales growth into 2025. The campaign is designed to generate over 4,000,000 projected views in 12 months, reaching more than 45,000 behavioral health decision makers. SOBRsafe is partnering with prominent national agencies for public relations, digital, and social media marketing. CEO Dave Gandini stated that this effort aligns with their strategy of establishing technology in the behavioral health vertical, following their first revenue-generating customers in 2024.